Results 341 to 350 of about 440,074 (404)
Nature Medicine, 2022 The recent emergence of the SARS-CoV-2 Omicron variant is raising concerns because of its increased transmissibility and its numerous spike mutations, which have the potential to evade neutralizing antibodies elicited by COVID-19 vaccines.
Carolina Lucas +2 more
exaly +2 more sources
Nature Medicine, 2021 Currently approved viral vector-based and mRNA-based vaccine approaches against coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination.
Joana Barros-Martins +2 more
exaly +2 more sources
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
Nature Medicine, 2021 Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in Germany, although data on immunogenicity and reactogenicity are not available.
Tina Schmidt, David Schub, Janine Mihm
exaly +2 more sources
Nature Medicine, 2022 The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and the waning of vaccine-elicited neutralizing antibodies suggests that additional coronavirus disease 2019 (COVID-19) vaccine doses may be needed for individuals who
Jingxin Li, Lihua Hou, Pengfei Jin
exaly +2 more sources
Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination
Nature, 2021 Following severe adverse reactions to the AstraZeneca ChAdOx1-S-nCoV-19 vaccine1,2, European health authorities recommended that patients under the age of 55 years who received one dose of ChAdOx1-S-nCoV-19 receive a second dose of the Pfizer BNT162b2 ...
Bruno Pozzetto +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Nature Immunology, 2020Annika Nelde +2 more
exaly +2 more sources
Transmission of trained immunity and heterologous resistance to infections across generations
Nature Immunology, 2021Jorge Domínguez-Andrés +2 more
exaly +2 more sources
Vaccine, 2016
The heterologous or non-specific effects (NSEs) of vaccines, at times defined as "off-target effects" suggest that they can affect the immune response to organisms other than their pathogen-specific intended purpose. These NSEs have been the subject of clinical, immunological and epidemiological studies and are increasingly recognized as an important ...
Mitra Saadatian-Elahi +8 more
openaire +3 more sources
The heterologous or non-specific effects (NSEs) of vaccines, at times defined as "off-target effects" suggest that they can affect the immune response to organisms other than their pathogen-specific intended purpose. These NSEs have been the subject of clinical, immunological and epidemiological studies and are increasingly recognized as an important ...
Mitra Saadatian-Elahi +8 more
openaire +3 more sources
Heterologous Sarcomas of the Uterus
International Journal of Gynecological Pathology, 1982Three cases of heterologous sarcomas of the uterus are presented. Two were mixed tumors; one was a lipoleiomyosarcoma; and one was an osteogenic sarcoma with leiomyosarcoma. The third was a rhabdomyosarcoma. These tumors are believed to behave more aggressively than mixed mesodermal tumors. Six months after initial diagnosis, the lipolieomyosarcoma had
M, Vakiani, J, Mawad, A, Talerman
openaire +2 more sources
Heterology: the shadows of a shade
Cladistics, 2007AbstractThe recent proposition to name some similarities not due to common ancestry as examples of heterology is discussed from a historical point of view. The use of an elaborate terminology for various kinds of similarities is examined and rejected in favor of dealing with homology and non‐homology.© The Willi Hennig Society 2006.
David M, Williams, Malte C, Ebach
openaire +2 more sources